About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Intranasal Steroids and the Nasal Ocular Response

NCT00473915·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Chicago

With

GlaxoSmithKline

Age

18–45

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

1. Males and females between 18 and 45 years of age.
2. History of grass and/or ragweed allergic rhinitis.
3. Positive skin test to grass and/or ragweed antigen.
4. Positive response to screening nasal challenge.

You may not be if

1. Physical signs or symptoms suggestive of renal, hepatic or cardiovascular disease.
2. Pregnant or lactating women.
3. Upper respiratory infection within 14 days of study start.

The record

StatusCompleted

PhasePhase 4

Taking part20

StartedApr 2007

UpdatedJun 3, 2013

Conditions

Seasonal Allergic Rhinitis

Where1

University of Chicago
Chicago, Illinois, United States

Clareo Health | Intranasal Steroids and the Nasal Ocular Response